首页 › 基金 › Sofinnova Investments, Inc. › EWTX
Sofinnova Investments, Inc. 对 EWTX 的持仓历史
EDGEWISE THERAPEUTICS INC · 医疗保健
Sofinnova Investments, Inc. 在 Q2 2026 的 13F 申报中披露持有 EWTX(EDGEWISE THERAPEUTICS INC)380,923 股,市值约 US$15.5M,约占其申报组合的 0.82%,在其申报持仓中市值排名第 32 位。 Sofinnova Investments, Inc. 最近 9 个申报季度中有 9 个季度披露了 EWTX 持仓,最早可追溯至 Q2 2024。
最后更新: 2026-10-24 · 来源: SEC EDGAR Form 13F-HR
Sofinnova Investments, Inc. 对 EWTX 的持仓演变
Sofinnova Investments, Inc. 于 Q2 2024 首次披露 EWTX 持仓:475,691 股(约 US$8.6M)。 该持仓在 Q2 2026 达到峰值 380,923 股,市值约 US$15.5M。 在 9 次申报中,Sofinnova Investments, Inc. 2 次增持、6 次减持、0 次保持不变。 最近一期申报(Q2 2026)显示持股 380,923 股、市值约 US$15.5M,环比减持 -5,575 股。。 持仓曾出现大幅变动:Q2 2025 增持约 124% (随后一个季度股价上涨 24%)、Q3 2025 减持约 27% (随后一个季度股价上涨 53%)。
逐季持仓明细
| 季度 | 股数 | 金额 | 变化 |
|---|---|---|---|
| Q2 2024 | 475.69K | $8.57M | 新进 |
| Q3 2024 | 384.77K | $10.27M | 减持 |
| Q4 2024 | 402.77K | $10.75M | 增持 |
| Q1 2025 | 320.40K | $7.05M | 减持 |
| Q2 2025 | 716.87K | $9.40M | 增持 |
| Q3 2025 | 520.24K | $8.44M | 减持 |
| Q4 2025 | 437.82K | $10.86M | 减持 |
| Q1 2026 | 386.50K | $12.17M | 减持 |
| Q2 2026 | 380.92K | $15.48M | 减持 |
折线上的点按变动类型着色;缺失季度表示该季未申报持仓。
关于 EWTX 与 13F 数据
EWTX(EDGEWISE THERAPEUTICS INC)属于医疗保健行业。我们追踪的基金中还有 47 只申报持有 EWTX,申报仓位最大的包括:ORBIMED ADVISORS LLC (US$630.5M), Paradigm Biocapital Advisors LP (US$415.1M), RA CAPITAL MANAGEMENT, L.P. (US$341.0M)。 根据美国 SEC 规定,管理资产超过 1 亿美元的机构投资者须在每季度结束后 45 天内提交 13F 表,披露其美股多头持仓。该数据不包含空头、大部分期权及海外持仓,因此应将其视为季度快照而非实时仓位。
其它持有 EWTX 的基金
- ORBIMED ADVISORS LLC 15.52M 股 · $630.52M · Q2 2026
- Paradigm Biocapital Advisors LP 10.22M 股 · $415.05M · Q2 2026
- RA CAPITAL MANAGEMENT, L.P. 8.39M 股 · $341.00M · Q2 2026
- Novo Holdings A/S 5.35M 股 · $217.37M · Q2 2026
- DRIEHAUS CAPITAL MANAGEMENT LLC 4.73M 股 · $192.12M · Q2 2026
- PERCEPTIVE ADVISORS LLC 4.37M 股 · $177.71M · Q2 2026
- BAKER BROS. ADVISORS LP 3.70M 股 · $150.40M · Q2 2026
- Siren, L.L.C. 3.18M 股 · $129.39M · Q2 2026
- Cormorant Asset Management, LP 2.51M 股 · $101.98M · Q2 2026
- Integral Health Asset Management, LLC 2.00M 股 · $81.26M · Q2 2026
- BRAIDWELL LP 2.00M 股 · $81.14M · Q2 2026
- MPM BioImpact LLC 1.62M 股 · $65.85M · Q2 2026
更多关于 Sofinnova Investments, Inc.
常见问题
How long has Sofinnova Investments, Inc. held EWTX?
Sofinnova Investments, Inc. has disclosed EWTX holdings in 9 of the last 9 reported quarters, going back to Q2 2024.
What is Sofinnova Investments, Inc.'s current position in EWTX?
As of Q2 2026, Sofinnova Investments, Inc. holds 380.92K shares of EWTX (EDGEWISE THERAPEUTICS INC), valued at $15.48M, representing 0.82% of its reported portfolio and ranking #32.
Has Sofinnova Investments, Inc. been buying or selling EWTX?
In the latest 13F filing (Q2 2026), Sofinnova Investments, Inc. reduced its position in EWTX. The position peaked in Q2 2026 at 380.92K shares.
Which other funds hold EWTX?
Other major institutional holders of EWTX include ORBIMED ADVISORS LLC, Paradigm Biocapital Advisors LP, RA CAPITAL MANAGEMENT, L.P., among 47 funds with disclosed positions.
Where does this data come from?
All figures are computed from SEC Form 13F quarterly filings, which institutional investment managers must file within 45 days of quarter end for long positions of $100,000 or more.